Loading...
Baculovirus-free insect cell expression system for high yield antibody and antigen production.
Korn, Janin Schäckermann, Dorina Kirmann, Toni Bertoglio, Federico Steinke, Stephan Heisig, Janyn Ruschig, Maximilian Rojas, Gertrudis Langreder, Nora Wenzel, Esther Veronika
Korn, Janin
Schäckermann, Dorina
Kirmann, Toni
Bertoglio, Federico
Steinke, Stephan
Heisig, Janyn
Ruschig, Maximilian
Rojas, Gertrudis
Langreder, Nora
Wenzel, Esther Veronika
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-12-07
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 3.96 MB
Other Titles
Abstract
Mammalian cells are the most commonly used production system for therapeutic antibodies. Protocols for the expression of recombinant antibodies in HEK293-6E cells in different antibody formats are described in detail. As model, antibodies against Kallikrein-related peptidase 7 (KLK7) were used. KLK7 is a key player in skin homeostasis and represents an emerging target for pharmacological interventions. Potent inhibitors can not only help to elucidate physiological and pathophysiological functions but also serve as a new archetype for the treatment of inflammatory skin disorders. Phage display-derived affinity-matured human anti-KLK7 antibodies were converted to scFv-Fc, IgG, and Fab formats and transiently produced in the mammalian HEK293-6E system. For the production of the corresponding antigen-KLK7-the baculovirus expression vector system (BEVS) and virus-free expression in Hi5 insect cells were used in a comparative approach. The target proteins were isolated by various chromatographic methods in a one- or multistep purification strategy. Ultimately, the interaction between anti-KLK7 and KLK7 was characterized using biolayer interferometry. Here, protocols for the expression of recombinant antibodies in different formats are presented and compared for their specific features. Furthermore, biolayer interferometry (BLI), a fast and high-throughput biophysical analytical technique to evaluate the kinetic binding constant and affinity constant of the different anti-KLK7 antibody formats against Kallikrein-related peptidase 7 is presented.
Citation
Sci Rep. 2020 Dec 7;10(1):21393. doi: 10.1038/s41598-020-78425-9.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Other
Other
Language
en
Description
Series/Report no.
ISSN
EISSN
2045-2322
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International